Women Abuse and the Role of the Family Doctor.

NCT ID: NCT00185016

Last Updated: 2005-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2003-03-31

Study Completion Date

2004-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study tested a training to improve recognition of abused female patients in family practice.Effect measures of the training were: number of reported cases wherein the doctor suspected and discussed partner abuse and the number of non-obviuos reasons to suspect partner abuse.We assumed that following a training would improve the recognition of abused women.

Secondary to this trial we explored gender differences of family doctors in discussing partner abuse and we interviewed women recently identified by their family doctor. Medical histories of recently identified abused women were studied to assess health problems and health-care utilisation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Improved Recognition of Partner Abuse Gender Differences in Discussing Partner Abuse Abused Women's Expectations,Experiences Abused Women's Health Care Utilisation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

intimate partner abuse gender education attitude family doctor health care utilisation abused women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

ECT

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

a training to improve recognition of partner abuse.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Theia Foundation, Zilveren Kruis Achmea

UNKNOWN

Sponsor Role collaborator

Radboud University Medical Center

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Toine LM Lagro-Janssen, PhD/MD/FP

Role: STUDY_CHAIR

Radboud University Medical Centre Nijmegen

Sylvie H Lo Fo Wong, MD/FP

Role: PRINCIPAL_INVESTIGATOR

Radboud University Medical Centre, Nijmegen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Radboud University Medical Centre

Nijmegen, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Theia 200173

Identifier Type: -

Identifier Source: secondary_id

1,SLFW

Identifier Type: -

Identifier Source: org_study_id